CS203352B1 - Method of treatment of fermentation substrate - Google Patents

Method of treatment of fermentation substrate Download PDF

Info

Publication number
CS203352B1
CS203352B1 CS56978A CS56978A CS203352B1 CS 203352 B1 CS203352 B1 CS 203352B1 CS 56978 A CS56978 A CS 56978A CS 56978 A CS56978 A CS 56978A CS 203352 B1 CS203352 B1 CS 203352B1
Authority
CS
Czechoslovakia
Prior art keywords
cephalosporin
pat
urea
fermentation broth
fermentation
Prior art date
Application number
CS56978A
Other languages
Czech (cs)
Slovak (sk)
Inventor
Eva Lacinova
Richard Frimm
Ladislav Welward
Rudolf Kosalko
Original Assignee
Eva Lacinova
Richard Frimm
Ladislav Welward
Rudolf Kosalko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eva Lacinova, Richard Frimm, Ladislav Welward, Rudolf Kosalko filed Critical Eva Lacinova
Priority to CS56978A priority Critical patent/CS203352B1/en
Publication of CS203352B1 publication Critical patent/CS203352B1/en

Links

Landscapes

  • Cephalosporin Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Description

(54) Spósob úpravy farmentačnoj pódy ·(54) Treatment method farmentačnoj pody ·

Vynález sa týká sposobu úpravy fermentačnej p3dy před izoláciou cefalosporínu C, na syntetických živiciach.The invention relates to a process for treating fermentation broth prior to isolation of cephalosporin C on synthetic resins.

Získanie cefalosporínu C čistěním ferměntačnej p6dy navazuje na jeho fermentačnú přípravu pomocou mikroorganizmov rodu Cephalosporium, napr. kmeúom Cephalosporium acremonium ATCC 14 553, pričom médium obsahuje biologicky aktívnu látku /Crawford K. a kol.: Antibiotics production by a species of Cephalosporium. J. Gen. Microbiol. £ /1952/, str. 47-59; Hewitt W.The recovery of cephalosporin C by purification of the fermentation broth follows its fermentation preparation using microorganisms of the genus Cephalosporium, e.g. strain Cephalosporium acremonium ATCC 14 553, wherein the medium contains a biologically active substance / Crawford K. et al .: Antibiotics production by a species of Cephalosporium. J. Gen. Microbiol. £ (1952), p. 47-59; Hewitt W.

L.: The cephalosporins. The Journal of infections Piseares 128, /1973/. str. 312.L .: The Cephalosporins. The Journal of Infections Piseares 128 (1973). p. 312th

Takéto fermentačné postupy sa uvádzajú tiež napr. vo švajčiarskych patentoch č. 570 460, č. 565 246, č. 570 459, v britských patentoch č. 820 422, v US patente č. 3 082 155 a v patente NSR č. 1 492 053. V týchto patentoch sa uvádzajú tiež určité postupy na získanie a čistenie cefalosporínu C zo surověj fermentačnej pódy.Such fermentation processes are also disclosed e.g. U.S. Pat. 570 460, no. 565 246, no. No. 570,459, in British Pat. 820,422, U.S. Pat. 3,082,155 and in German patent no. These patents also disclose certain processes for recovering and purifying cephalosporin C from a crude fermentation stage.

Spósoby čistenia cefalosporínu C z fermentačnej pódy cez* N-deriváty .například N-haloalkanoyl, alebo N-benzoyl, extrahujúce sa vhodnými organickými rozpúštadlami sú popísané v US pat. č. 3 739 002, č. 3 835 129, v pat. NSR č. 2 255 973, č. 2 157 693 a v pat. ZSSR číslo 282 174.Methods for purifying cephalosporin C from the fermentation broth via N-derivatives such as N-haloalkanoyl or N-benzoyl, extracted with suitable organic solvents, are described in US Pat. no. No. 3 739 002, no. No. 3,835,129, in U.S. Pat. NSR no. 2 255 973, no. 2,157,693 and in U.S. Pat. USSR number 282 174.

Významnou skupinou izolačnýeh postupov sú spósoby založené na deiení pomocou syntetických ionexov, napr. franc. pat. 6. 1 353 113, brit pat. č. 1 210 823, č. 1 036 125, resp. australsky pat. č. 251 922, 455 753, švéd. pat. č. 198 707, 215 561, 198 707, 541 579.An important group of isolation procedures are synthetic ion exchange methods, e.g. France. pat. 6. 1,353,113, British Pat. no. 1 210 823, no. 1,036,125, respectively. Australian Pat. no. 251 922, 455 753, Sweden. pat. no. 198,707, 215,561, 198,707, 541,579.

Hydrofilné antibiotiká, napr. cefalosporín C, sa móžu zo zložitých suspenzných fermentačných pód obsahujúcich velké množstvo rozpuštěných organických a anorganických zlúčenín získat pomocou makroporéznych neionogenných sorbentov, napr. typu Amberlit XAD-2, Ostion SP-1, Diaion HP-20.Hydrophilic antibiotics, e.g. cephalosporin C, can be obtained from complex suspension fermentation stages containing a large amount of dissolved organic and inorganic compounds using macroporous non-ionic sorbents, e.g. Type Amberlit XAD-2, Ostion SP-1, Diaion HP-20.

Izolácie pomocou týchto sorbentov sú úvádzané napr. v US pat. č. 3 725 400, resp. ZSSR pat. č. 350 265.Insulations with these sorbents are contemplated e.g. in US Pat. no. 3,725,400, respectively. USSR pat. no. 350 265.

Podmienkou zdárného priebehu izolácie na živiciach jé předpoklad mat k dispozfcii čirý bThe condition of a successful isolation process on the resins is the assumption that clear b

filtrát, ktorý slúži ako nástrek na hlavu kolon. Pri čistění cefalosporinů C sa pomocou anorganických kyselin upravuje pH na 2,7! čím sa má vyvolat koagulácia bielkovín.filtrate, which serves as a spray on the head of the columns. In the purification of cephalosporins C, the pH is adjusted to 2.7 with inorganic acids. thereby causing protein coagulation.

Po filtrác*ii v priebehu adsorpcie dochádza však k postupnému ďalšiemu koagulovániu níektorýeh rozpustných látok, hlavně bielkovín, pričom takto znečistěný filtrát znižuje kapacitu sorbentov a stažuje další priebeh izolačného postupu včítane regenerácie sorhentov.However, after filtration during the adsorption, there is a gradual further coagulation of some soluble substances, mainly proteins, whereby the impure filtrate reduces the capacity of the sorbents and withdraws the further course of the isolation process, including the regeneration of the sorhents.

Hoře uvedená nedostatky odstraňuje spósob úpravy fermentačnej p3dy, ktorého podstata spočívá v tom, že k fermentačnej póde po biosyntéze cefalosporinů C sa přidá pri pH 2,5-4,0 5 až 30 mg/ml močoviny,' póda sa sfiltruje a podrobí ďalšej purifikácii. Postup sa móže doplnit ešte prídavkom 0,5 až 52 anionaktívneho detergentu.The above-mentioned drawbacks eliminate the method of treatment of the fermentation broth, which consists in adding to the fermentation broth after the cephalosporin C biosynthesis at a pH of 2.5-4.0 5 to 30 mg / ml urea, filtering and subjecting the pod to further purification . The process may be supplemented by the addition of 0.5-52 anionic detergent.

močovině je známe, že móže u niektorých labilných nekovalentných vázieb rušit terciálnu Strukturu bielkovín a tým spósobit ich denaturáciu.It is known in the urea that, in some labile non-covalent bonds, it can disrupt the tertiary structure of proteins and thereby cause their denaturation.

Tento denaturačný efekt je velmi potřebný, pretože pre malú termostabilitu cefalosporín C nie je reálna termokoagulácia surověj fermentačnej pódy.,This denaturation effect is very needed because, due to the low thermostability of cephalosporin C, the thermoagulation of the raw fermentation broth is not realistic.

Prídavok tejto látky spóaobuje zniženie obsahu rozpuštěných proteinov v získanom filtráte, čo v konečnom efekte zlepšuje adsorpčnú kapacitu a tiež regeneráciu použitých živic.The addition of this material results in a reduction in the dissolved protein content of the filtrate obtained, which ultimately improves the adsorption capacity as well as the regeneration of the resins used.

Anionaktívne detergenty okrem čistiaceho účinku pósobia aj ako antibakteriálne látky, čo je velmi dóležité ako prevencia před možnou mikrobiálnou kontamináciou náplní stlpcov.In addition to the cleaning effect, anionic detergents also act as antibacterial agents, which is very important as a prevention of possible microbial contamination of column fillings.

V tejto skupině detergentov tvoria velkú skupinu přídavky, ktorých hlavným podielom je laurylsulfát sodný. Komerčně sa osvědčil najmá TERGITOL.In this group of detergents, a large group of additives are made up, the major part being sodium lauryl sulfate. TERGITOL, in particular, has proven commercially.

V dalšom je vynález bližšie objasněný v prikladoch postupov bez toho, že by sa na tieto akokolvek obmedzoval.In the following, the invention is explained in more detail in the examples of procedures without being limited thereto.

Přiklad 1Example 1

Surová fermentačná póda sa upraví 10 mg močoviny na 1 ml pódy, 15 minút mieša a potom okyselí s kyselinou sírovou ztiedenou v pomere 1:4 na pH 2,5. Biomasa a ďalšie nerozpustné zložky sa filtráciou oddelia od hnedo sfarbeného čirého filtrátu, obsahujúceho 3 600 «ag/ml cefalosporínu C.The crude fermentation platform is adjusted with 10 mg of urea per ml of soil, stirred for 15 minutes and then acidified with a 1: 4 dilution of sulfuric acid to pH 2.5. The biomass and other insoluble ingredients are separated from the brown colored clear filtrate containing 3600 g / ml cephalosporin C by filtration.

000 ml tohoto filtrátu sa perkoluje cez 3 970 ml náplně živice Ostion SP-1 pri mernora zataženi 1 h Zbytok adsorbátu z náplně sa vytěsní 2 000 ml vody a neviazaný cefalosporín C desorbujeme 152yným vodným roztokom acetonu.000 ml of this filtrate was percolated through a 3 970 ml Ostion SP-1 resin cartridge at a mernor load of 1 h. The adsorbate residue was displaced from the cartridge by 2,000 ml of water and desorbed with unbound cephalosporin C with a 152% aqueous acetone solution.

Získá se 3 060 ml eluátu s obsahom 5 000 ^ug/ml cefalosporinů C, ktorý sa podrobí dalšej purifikácii.3060 ml of an eluate containing 5,000 µg / ml of cephalosporins C are obtained, which is subjected to further purification.

Použitý Ostion SP-, sa regeneruje 12 1 252-ného vodného roztoku acetonu s obsahom 22 NaOH. Potom sa náplň premyje 2 1 12-nej kyseliny sírovej a nakoniec 12 1 vody.The Ostion SP- used was regenerated with 12 L of a 252 N aqueous solution of acetone containing 22 NaOH. The cartridge was then washed with 2 L of 12-L sulfuric acid and finally with 12 L of water.

Příklad 2Example 2

Spósob ako v příklade 1, s tým rozdielom, že k surověj fermentačnej póde sa přidá 5 mg močoviny na 1 ml pódy a cefalosporín C sa zo živice eluuje 0,05 N vodným roztokom NaOH. Na 4 000 ml Ostionu SP-1 sa adsorbuje 5 450-ml čirého filtrátu obsahujúceho 3 100 yug/ml cefalosporínu C. Tento sa desorbuje zo sorbentu 0,05 N vodným roztokom NaOH, pričom v 3 800 ml eluátových podieloch sa získá 82 2 z celkového množstva cefalosporinů C.Method as in Example 1, except that 5 mg of urea per ml of soil was added to the crude fermentation broth and cephalosporin C was eluted from the resin with 0.05 N aqueous NaOH. 5 450-ml of a clear filtrate containing 3 100 µg / ml of cephalosporin C is adsorbed onto 4000 ml of Ostion SP-1. This is desorbed from the sorbent with 0.05 N aqueous NaOH, yielding 82 2 of the 3 800 ml eluates. total amount of Cephalosporins C.

Příklad 3Example 3

Spósob ako v příklade 1, s tým rozdielom, že k surověj fermentačnej póde sa přidá 30 mg močoviny na 1 ml pódy a pH sa upraví s kyselinou sírovou na 2,9 /1:4/. Získaný čirý filtrát sa podrobí ďalšej purifikácii na Ostione SP-1.Method as in Example 1, except that 30 mg of urea per ml of soil was added to the crude fermentation broth and the pH was adjusted to 2.9 (1: 4) with sulfuric acid. The clear filtrate obtained is subjected to further purification on Ostion SP-1.

Příklad 4Example 4

Spósob ako v příklade 1, len s tým rozdielom, že k surověj fermentačnej póde sa přidá 10 mg močoviny na 1 ml pódy a 0,5 promile anionaktívneho detergentu Tergitolu. Takto upravená surová fermentačná póda sa sfiltruje a čirý filtrát podrobí ďalšej purifikácii.Method as in Example 1, except that 10 mg of urea per ml of soil and 0.5 per mille of anionic detergent Tergitol are added to the crude fermentation broth. The crude fermentation platform thus treated is filtered and the clear filtrate subjected to further purification.

Příklad 5Example 5

Sposob ako v příklade 1, s tým rozdielom, že k surověj fermentačnej póde sa přidá 5 mg/ml močoviny a 5 promile, anionaktívneho detergentu Tergitolu a pH sa upraví na 4,0 s kyselinou sírovou /1:4 /. Takto upravená fersnentačná podá sa sfiltruje a filtrát podrobí ďalšej purifikácii.Method as in Example 1, except that 5 mg / ml urea and 5 per mille of anionic detergent Tergitol are added to the crude fermentation broth and the pH is adjusted to 4.0 with sulfuric acid (1: 4). The treated fermentation is then filtered and the filtrate subjected to further purification.

Claims (2)

3 203352 Příklad 5 Sposob ako v příklade 1, s tým rozdielom, že k surověj fermentačnej póde sa přidá5 mg/ml močoviny a 5 promile, anionaktívneho detergentu Tergitolu a pH sa upraví na 4,0 s ky-selinou sírovou /1:4 /. Takto upravená fersnentačná podá sa sfiltruje a filtrát podrobí ďalšejpurifikácii. PŘEĎME T VYNÁLEZUExample 5 Method as in Example 1, except that 5 mg / ml of urea and 5 ml of anionic detergent Tergitol are added to the crude fermentation broth and the pH is adjusted to 4.0 with sulfuric acid / 1: 4 / . The treated suspension is filtered and the filtrate is further purified. SUMMARY OF THE INVENTION 1. Sposob úpravy fermentačnej pódy po biosyntéze cefalosporinuže k pode sa přidá, pri pH 2,5 - 4,0, 5 - 30 mg/.ml močoviny, podá sašej purifikácii*1. A method for treating a fermentation process after biosynthesis of cephalosporin to the base is added, at pH 2.5-4.0 5-30 mg / ml urea, to give purification * 2. Spósob podlá bodu 1, vyznačený tým, že do fermentačnej pody0,5 - 5 % anionaktívneho detergentu. C, vyznačujúci sa tým,sfiltruje a podrobí <fal- sa ešte připadne přidá Sevfrografia. n. p- xivod 7. Most2. Process according to claim 1, characterized in that the anionic detergent is present in an amount of 0.5 - 5%. C, which is then filtered and subjected to the addition of Sevfrography. n. p- xivod 7. Most
CS56978A 1978-01-27 1978-01-27 Method of treatment of fermentation substrate CS203352B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS56978A CS203352B1 (en) 1978-01-27 1978-01-27 Method of treatment of fermentation substrate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS56978A CS203352B1 (en) 1978-01-27 1978-01-27 Method of treatment of fermentation substrate

Publications (1)

Publication Number Publication Date
CS203352B1 true CS203352B1 (en) 1981-02-27

Family

ID=5337989

Family Applications (1)

Application Number Title Priority Date Filing Date
CS56978A CS203352B1 (en) 1978-01-27 1978-01-27 Method of treatment of fermentation substrate

Country Status (1)

Country Link
CS (1) CS203352B1 (en)

Similar Documents

Publication Publication Date Title
US2528022A (en) Purification of antibiotics by ion exchange procedures
DK173231B1 (en) Method for Extraction of Glycopeptidic Antibiotics
US4440753A (en) Purification of glycopeptide antibiotics using non-functional resins
DE2021696C3 (en) Method of Isolating Cephalosporin C.
CA1283072C (en) Process for the isolation and separation of lysozyme and avidin from eggwhite
CH660012A5 (en) PROCEDURE FOR THE PURIFICATION OF THYLOSIN.
DE69629551T2 (en) COMBINED PROCESS FOR PURIFYING VANCOMYCIN HYDROCHLORIDE
CH370871A (en) Process for obtaining an antibiotic fermentation product from a fermentation broth
DE69628002T2 (en) PRODUCTION OF CLAVUNALATE SALTS
JP3083369B2 (en) Teicoplanin recovery method
SK287315B6 (en) A method for polymyxin B isolation from fermented soil
DE60124868T2 (en) NEW RESINS AND THEIR USE FOR THE RECOVERY OF PROTEINS OR PEPTIDES
US5061627A (en) Method for preparing enzymes from crustaceans
Zittle et al. Use of butanol in the purification of the alkaline phosphatase of bovine milk
CS203352B1 (en) Method of treatment of fermentation substrate
DE68911503T2 (en) RECOVERY OF UROKINASE COMPOUNDS.
US5215908A (en) Process for recovery and purification of chymosin
JPS6160050B2 (en)
JPH01112987A (en) Avoparcin which doesn&#39;t contain highly effective biomass and method for its manufacture
DE2555587C3 (en) Procedure for the extraction and collection of kallidinogenase
DE4318235B4 (en) Process for the preparation of high purity deferoxamine salts
US2834711A (en) Production of bacitracin
DE3922278A1 (en) METHOD FOR PRODUCING FREE EPSILON POLYLYSINE
KR900009053B1 (en) Method for preparing avoparsin alkyl sulfate complex compound of mycelium free high titer
US2540238A (en) Purification and recovery of streptomycin